You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb2664268 |
|---|---|
| Category | Small Molecules |
| Description | ORIC-944 TFA is a selective, orally active conformational inhibitor that targets the EED subunit of polycomb repressive complex 2 (PRC2). It demonstrates synergistic effects when used in conjunction with androgen receptor pathway inhibitors (ARPI) in the study of metastatic prostate cancer. |
| Storage | -20°C |
| Research Area | Epigenetics & Chromatin |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review(Recommended: An additional animal making an allowance for loss during the experiment)
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)